| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |